Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: <scp>Real‐world</scp> findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry-Reference-Cited by-同舟云学术

Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real‐world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry

Published:2022-06-21 Issue:3 Volume:109 Page:197-204
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Höchsmann Britta¹,de Fontbrune Flore Sicre²,Lee Jong Wook³,Kulagin Alexander D.⁴^ORCID,Hillmen Peter⁵,Wilson Amanda⁶,Marantz Jing L.⁶,Schrezenmeier Hubert¹

Affiliation:

1. Institute of Transfusion Medicine, University of Ulm, and Institute for Clinical Transfusion Medicine and Immunogenetics German Red Cross Blood Transfusion Service Baden‐Württemberg‐Hessen and University Hospital Ulm Ulm Germany

2. Hôpital Saint Louis Paris France

3. Department of Hematology, Seoul St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

4. Pavlov First Saint Petersburg State Medical University St. Petersburg Russia

5. St. James's University Hospital Leeds UK

6. Alexion, AstraZeneca Rare Disease Boston Massachusetts USA

Funder

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Hematology,General Medicine

Link